Abstract:Resveratrol is a valuable plant polyphenol. It is currently obtained primarily through plant extraction, which is difficult to obtain in large quantities over a long period of time due to the scarcity of natural raw materials. Therefore, it is necessary to develop a simple and cost-saving method for producing resveratrol. In this study, the genes encoding key enzymes for resveratrol synthesis (HaTAL1, AtPAL2, AtC4H, At4CL2, and VvSTS) were introduced into the wild-type strain of Scheffersomyces stipitis to construct strain Ss05, which achieved the resveratrol yield of 55.28 mg/L. Subsequently, the supply of p-coumaric acid and malonyl-CoA precursors was enhanced by overexpression of the feedback-insensitive 3-deoxy-d-arabino-heptulonate-7-phosphate synthase mutant SsARO4K221L and chorismate mutase mutant SsARO7G139S, knockout of the pyruvate decarboxylase gene (PDC1), and overexpression of the acetyl-CoA carboxylase mutant SsACC1S650A, S1152A. On this basis, the copy number of key genes was increased to create the engineered strain Ss17, which achieved the resveratrol yield of 150.56 mg/L. Finally, 558.40 mg/L resveratrol was produced by fed-batch fermentation of glucose with strain Ss17 in a 5-L fermenter for 128 h. In this study, we employed synthetic biology to construct an engineered strain of S. stipitis for the synthesis of resveratrol from a simple carbon source and then scaled up the microbial fermentation in a bioreactor, providing an important reference for the biosynthesis of aromatic compounds in S. stipitis.